Newer GABA derivatives for the treatment of epilepsy including febrile seizures: A bioisosteric approach
- 31 December 2008
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 43 (12), 2650-2655
- https://doi.org/10.1016/j.ejmech.2008.01.036
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Discovery of 4-Aminobutyric Acid Derivatives Possessing Anticonvulsant and Antinociceptive Activities: A Hybrid Pharmacophore ApproachJournal of Medicinal Chemistry, 2007
- Design and synthesis of anticonvulsants from a combined phthalimide–GABA–anilide and hydrazone pharmacophoreEuropean Journal of Medicinal Chemistry, 2007
- An Update on GABA Analogs for CNS Drug DiscoveryRecent Patents on CNS Drug Discovery, 2006
- The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic DisordersCurrent Drug Metabolism, 2005
- Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazonesEuropean Journal of Medicinal Chemistry, 2002
- Emerging insights into the genesis of epilepsyNature, 1999
- (Aryloxy)aryl Semicarbazones and Related Compounds: A Novel Class of Anticonvulsant Agents Possessing High Activity in the Maximal Electroshock ScreenJournal of Medicinal Chemistry, 1996
- GABA receptor mechanisms in the central nervous systemProgress in Neurobiology, 1991
- Triazolines XIII: Δ2-1,2,3-Triazolines, a New Class ofAnticonvulsantsJournal of Pharmaceutical Sciences, 1984
- Epilepsy and γ-Aminobutyric Acid-Mediated InhibitionInternational review of neurobiology, 1975